Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension-Reference-Cited by-同舟云学术

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension

Published:2017-10-12 Issue:18 Volume:18 Page:1903-1919
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Kadowaki Takashi¹,Muto Satsuki²,Ouchi Yoshiumi²,Shimazaki Ryutaro²,Seino Yutaka³

Affiliation:

1. Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

2. R&D Division, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan

3. Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan

Funder

Kyowa Hakko Kirin

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1379990

Reference31 articles.

1. New glycemic targets for patients with diabetes from the Japan Diabetes Society

2. Glycemic targets for elderly patients with diabetes

3. Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

4. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

5. Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of DPP‐IV inhibitors combined with basal insulin in the treatment of type 2 diabetes;Journal of Diabetes;2020-10-24

2. Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis;Diabetes Therapy;2020-09-02

3. Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial;Advances in Therapy;2019-09-03

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-08

5. Analysis and bio-analysis of omarigliptin, trelagliptin and alogliptin: Applied to biological samples and degradation kinetic study;Microchemical Journal;2019-07